Vitoc Vlad Insider Trades

Insider Trading History

Track insider trading activity for Vitoc Vlad. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.14M 800,000 shares
Last Trade
Apr 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 800,000 shares
$1.28
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.26M 881,421 shares
Last Trade
Nov 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$57k 50,000 shares
$1.14
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.29M 903,421 shares
Last Trade
Nov 28, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$57k 50,000 shares
$1.14
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.22M 853,421 shares
Last Trade
Nov 26, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.1k 22,000 shares
$1.05
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.19M 831,421 shares
Last Trade
Nov 25, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.2k 10,500 shares
$0.97
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.17M 820,921 shares
Last Trade
Nov 24, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$9.9k 10,000 shares
$0.99
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.16M 810,921 shares
Last Trade
Nov 21, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.66k 1,800 shares
$0.92
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $572k 400,000 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$704k 400,000 shares
$1.76
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $572k 400,000 shares
Last Trade
Feb 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$724k 400,000 shares
$1.81
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $214k 149,519 shares
Last Trade
Nov 05, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$122k 39,963 shares
$3.06
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $286k 200,000 shares
Last Trade
Apr 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$588k 200,000 shares
$2.94
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $286k 200,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 200,000 shares
$1.41
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $177k 123,760 shares
Last Trade
May 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$309k 123,760 shares
$2.50
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.16M 809,121 shares
Last Trade
Apr 28, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10k 4,000 shares
$2.50
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.15M 805,121 shares
Last Trade
Apr 04, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.29k 925 shares
$3.56
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.15M 804,196 shares
Last Trade
Apr 03, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.81k 1,375 shares
$3.50
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.15M 802,821 shares
Last Trade
Mar 31, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.17k 1,495 shares
$3.46
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.15M 801,326 shares
Last Trade
Mar 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$703 205 shares
$3.43
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $286k 200,000 shares
Last Trade
Mar 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$820k 200,000 shares
$4.10
$1.43
MAIA Biotechnology
MAIA Biotechnology MAIA
10% owner, Chief Executive Officer
Holding Value $1.15M 801,121 shares
Last Trade
Mar 08, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.66k 1,581 shares
$4.21
$1.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up